Does LENVATINIB Cause Myocardial infarction? 276 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 276 reports of Myocardial infarction have been filed in association with LENVATINIB (Lenvima). This represents 0.8% of all adverse event reports for LENVATINIB.
276
Reports of Myocardial infarction with LENVATINIB
0.8%
of all LENVATINIB reports
36
Deaths
186
Hospitalizations
How Dangerous Is Myocardial infarction From LENVATINIB?
Of the 276 reports, 36 (13.0%) resulted in death, 186 (67.4%) required hospitalization, and 32 (11.6%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
Yes, Myocardial infarction is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which LENVATINIB Alternatives Have Lower Myocardial infarction Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE